VIDEO FROM ASCO
ASCO 2011: Blase Polite Discusses New Developments in Colorectal Cancer
November 11, 2011
Blase Polite, MD, assistant professor of medicine at the University of Chicago and the track leader for the GI Colorectal Scientific Program Committee at ASCO, discusses the latest research in the field of colorectal cancer.
ASCO 2011: Cytoreductive Surgery plus HIPEC for Metastatic Colon Cancer
October 3, 2011
David Ryan, MD discusses his debate with Paul H. Sugarbaker, MD during the ASCO session “Intraperitoneal Chemotherapy and Cytoreductive Surgery in Colon Cancer” and how in his view this type of treatment, as presented to the patient, creates a certain dynamic between the surgeon and medical oncologist, one of hope vs reality.
ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
September 23, 2011
Don Dizon, MD, Brown University, discusses the paradigm shift in the treatment of endometrial cancer with the use of medical therapy, including chemotherapy with biologics, mTOR inhibitors combined with chemotherapy, and targeted therapies.
ASCO 2011: Dr. Antoni Ribas Discusses the Impact of 2 New Drugs for the Treatment of Metastatic Melanoma
August 19, 2011
Dr. Antoni Ribas, UCLA's Jonsson Comprehensive Cancer Center and a presenter at this year's annual meeting of the American Society of Clinical Oncology, discusses the impact of 2 new drugs— ipilimumab (Yervoy) and vemurafenib (Zelboraf)—for the treatment of metastatic melanoma.
ASCO 2011: Steve Joffe Discusses Controversies in Phase I Clinical Trials
August 12, 2011
Steve Joffe, MD discusses the ethical challenges and controversies in phase I clinical cancer trials.